The Association of Perioperative Blood Transfusion with Survival Outcomes After Major Cancer Surgery: a Population-based Cohort Study in South Korea

Overview

Journal Surg Today

Specialty General Surgery

Date 2024 Jan 4

PMID 38175292

Authors

Saeyeon Kim

In-Ae Song

Tak Kyu Oh

Affiliations

Soon will be listed here.

Abstract

Purpose: The correlation between perioperative blood transfusions and the prognosis after major cancer surgery remains controversial. We investigated the association between perioperative blood transfusion and survival outcomes following major cancer surgeries and analyzed trends in perioperative blood transfusions.

Methods: Data for this population-based cohort study were obtained from the National Health Insurance Service of South Korea. Adult patients who underwent major cancer surgery between January 1, 2016, and December 31, 2020, were included. The primary endpoint was 90-day mortality.

Results: The final analysis included 253,016 patients, of which 55,094 (21.8%) received perioperative blood transfusions. In the multivariable logistic regression model, select factors, including neoadjuvant/adjuvant chemotherapy, an increased preoperative Charlson Comorbidity Index, moderate or severe liver disease, liver cancer surgery, and small bowel cancer surgery, were associated with an increased likelihood of blood transfusion. In the multivariable Cox regression model, patients who received blood transfusion had a significantly higher risk of 90-day mortality (hazard ratio: 5.68; 95% confidence interval: 5.37, 6.00; P < 0.001) than those who did not.

Conclusion: We identified potential risk factors for perioperative blood transfusions. Blood transfusion is associated with an increased 90-day mortality risk after major cancer surgery.

References

Schwartz R . Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm. 2007; 64(3 Suppl 2):S5-13. DOI: 10.2146/ajhp060601. View

Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P . The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004; 40(15):2293-306. DOI: 10.1016/j.ejca.2004.06.019. View

Murphy G, Reeves B, Rogers C, Rizvi S, Culliford L, Angelini G . Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007; 116(22):2544-52. DOI: 10.1161/CIRCULATIONAHA.107.698977. View

Khorana A, Francis C, Blumberg N, Culakova E, Refaai M, Lyman G . Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med. 2008; 168(21):2377-81. PMC: 2775132. DOI: 10.1001/archinte.168.21.2377. View

Connor J, OShea A, McCool K, Sampene E, Barroilhet L . Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes. Gynecol Oncol. 2018; 151(2):294-298. DOI: 10.1016/j.ygyno.2018.08.040. View

Kamei T, Kitayama J, Yamashita H, Nagawa H . Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg. 2009; 33(6):1240-6. DOI: 10.1007/s00268-009-9979-4. View

Rausei S, Ruspi L, Galli F, Tirotta F, Inversini D, Frattini F . Peri-operative blood transfusion in gastric cancer surgery: prognostic or confounding factor?. Int J Surg. 2014; 11 Suppl 1:S100-3. DOI: 10.1016/S1743-9191(13)60027-8. View

Pacelli F, Rosa F, Marrelli D, Pedrazzani C, Bossola M, Zoccali M . Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol. 2011; 18(6):1615-23. DOI: 10.1245/s10434-010-1543-9. View

Auvinen M, Zhao J, Lassen E, Lubenow N, Seger Mollen A, Watz E . Patterns of blood use in Sweden from 2008 to 2017: A nationwide cohort study. Transfusion. 2020; 60(11):2529-2536. DOI: 10.1111/trf.16092. View

10.

Ecker B, Simmons K, Zaheer S, Poe S, Bartlett E, Drebin J . Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program. JAMA Surg. 2016; 151(6):518-25. DOI: 10.1001/jamasurg.2015.5094. View

11.

Roubinian N, Escobar G, Liu V, Swain B, Gardner M, Kipnis P . Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014; 54(10 Pt 2):2678-86. PMC: 4197097. DOI: 10.1111/trf.12825. View

12.

Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T . Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007; 14(5):455-62. DOI: 10.1007/s00534-006-1194-1. View

13.

de Boer M, Molenaar I, Hendriks H, Slooff M, Porte R . Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg. 2005; 22(4):265-75. DOI: 10.1159/000088056. View

14.

Chen X, Feng X, Wang M, Yao X . Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies. Eur J Surg Oncol. 2020; 46(11):1998-2010. DOI: 10.1016/j.ejso.2020.06.046. View

15.

Zhou S, Wang X, Zhao C, Liu Q, Zhou H, Zheng Z . Laparoscopic vs open colorectal cancer surgery in elderly patients: short- and long-term outcomes and predictors for overall and disease-free survival. BMC Surg. 2019; 19(1):137. PMC: 6744685. DOI: 10.1186/s12893-019-0596-3. View

16.

Li Z, Liu C, Liu Y, Yao S, Xu B, Dong G . Comparisons between minimally invasive and open esophagectomy for esophageal cancer with cervical anastomosis: a retrospective study. J Cardiothorac Surg. 2020; 15(1):128. PMC: 7282040. DOI: 10.1186/s13019-020-01182-3. View

17.

Al-Refaie W, Parsons H, Markin A, Abrams J, Habermann E . Blood transfusion and cancer surgery outcomes: a continued reason for concern. Surgery. 2012; 152(3):344-54. DOI: 10.1016/j.surg.2012.06.008. View

18.

de Goede B, Klitsie P, Lange J, Metselaar H, Kazemier G . Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best Pract Res Clin Gastroenterol. 2012; 26(1):47-59. DOI: 10.1016/j.bpg.2012.01.010. View

19.

Fearon K, Jenkins J, Carli F, Lassen K . Patient optimization for gastrointestinal cancer surgery. Br J Surg. 2012; 100(1):15-27. DOI: 10.1002/bjs.8988. View

20.

Anderson C, Chari R . Chemotherapy liver injury. Surgery. 2010; 147(2):195-6. DOI: 10.1016/j.surg.2009.09.030. View